tDCS
DeviceDevice: verum tDCS real transcranial direct current stimulation,10 sessions, 2mA for 20 minutes Behavioral: VRT Vision restoration training, 10 sessions, 20 minutes
NCT Number: NCT02935413
The purpose of this Study is to determine whether non-invasive transcranial direct current stimulation (tDCS) is effective in increasing rehabilitation effects after stroke in visual Cortex.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 1 / Phase 2
Neurologisches Therapiezentrum Gmundnerberg, Altmünster, Austria
Visual field defects after posterior cerebral artery stroke can be improved by vision restoration training (VRT), but when combined with transcranial direct current stimulation (tDCS) which alters brain excitability, vision restoration can be potentiated in the chronic stage. Because it is possible that such therapy may be more effective during the early recovery phase after the stroke and can reach patients during the rehabilitation phase, investigators wished to explore the applicability, efficacy and safety of early intervention with a combined tDCS/VRT treatment.
Seven post-acute stroke homonymous hemianopia patients were assigned to 10 sessions of combined tDCS (2mA, 10 daily sessions of 15-20 min) and VRT. The primary outcome criterion was the pre-post change in perimetric detection thresholds in percent. The results were compared to 7 age and stroke lesion matched controls of our patient data pool who received standard rehabilitation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Device: verum tDCS real transcranial direct current stimulation,10 sessions, 2mA for 20 minutes Behavioral: VRT Vision restoration training, 10 sessions, 20 minutes
Standard rehabilitation procedures involving PC-based training of saccades and visual exploration
Time frame: 14-20 days post treatment,
University of Magdeburg
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02703870
Blindness, Brain Diseases
Altmünster, Austria
View Trial DetailsNCT06875206
Blindness, Brain Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07147660
Blindness, Brain Diseases
Kongsberg, Norway
View Trial DetailsNCT07105358
Blindness, Blindness, Cortical
Washington D.C., District of Columbia, United States
View Trial Details